Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Impact of Functional CYP2C19 and CYP2D6 Gene Variants on Treatment with Antidepressants in Young People with Depression: A Danish Cohort Study
Liv S. Thiele, Kazi Ishtiak‐Ahmed, Janne Pia Thirstrup, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 870-870
Open Access | Times Cited: 15

Showing 15 citing articles:

From genes to drugs: CYP2C19 and pharmacogenetics in clinical practice
Qamar Shubbar, Aminah Alchakee, Khaled Walid Issa, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Predictive Biomarkers and Personalized Therapy: Use of Pharmacogenetic Testing in a Scandinavian Perspective
Niels Westergaard, Trine Meldgaard Lund, Charlotte Vermehren
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 3
Open Access
Modern views on therapy with antidepressants on the background of their individual pharmacogenetics
О. А. Yakovleva, S. І. Semenenko, N Shcherbeniuk, et al.
Reports of Vinnytsia National Medical University (2025) Vol. 29, Iss. 1, pp. 168-172
Open Access
The Buzz Surrounding Precision Medicine: The Imperative of Incorporating It into Evidence-Based Medical Practice
Guido Muharremi, Renald Meçani, Taulant Muka
Journal of Personalized Medicine (2023) Vol. 14, Iss. 1, pp. 53-53
Open Access | Times Cited: 10
The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses
Ping Siu Kee, Simran Maggo, Martin A. Kennedy, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
A Bibliometric and Visual Analysis of Single Nucleotide Polymorphism Studies in Depression
Zi Zhang, Ye Yang, Wan Kong, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 2, pp. 302-322
Open Access | Times Cited: 6
Escitalopram Personalized Dosing: A Population Pharmacokinetics Repository Method
Xin Liu, Gehang Ju, Wenyu Yang, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 2955-2967
Open Access | Times Cited: 4
Impact of Pharmacogenomics on Pediatric Psychotropic Medication Prescribing in an Ambulatory Care Setting
Erica Tonti, Yee Ming Lee, Nathan P Gruenke, et al.
Journal of Child and Adolescent Psychopharmacology (2024) Vol. 34, Iss. 1, pp. 52-60
Closed Access | Times Cited: 1
CYP2C19 loss‐of‐function alleles are not associated with higher prevalence of gastrointestinal bleeds in those who have been prescribed antidepressants: Analysis in a British‐South Asian cohort
Emma Magavern, David A. van Heel, Damian Smedley, et al.
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 11, pp. 3432-3438
Open Access | Times Cited: 2
Precision Medicine in Antidepressants Treatment
Evangelia Eirini Tsermpini, Alessandro Serretti, Vita Dolžan
Handbook of experimental pharmacology (2023), pp. 131-186
Closed Access | Times Cited: 2
Validation of Pharmacogenomic Interaction Probability (PIP) Scores in Predicting Drug–Gene, Drug–Drug–Gene, and Drug–Gene–Gene Interaction Risks in a Large Patient Population
Kristine Ashcraft, Kendra Grande, Sara L. Bristow, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 12, pp. 1972-1972
Open Access | Times Cited: 3
Pediatric considerations for pharmacogenetic selective serotonin reuptake inhibitors clinical decision support
Michelle Liu, Katelyn M. Rossow, Angela Maxwell-Horn, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2022) Vol. 43, Iss. 7, pp. 691-704
Closed Access | Times Cited: 3
TÓXICOS NA CIDADE DO SOL: EPIDEMIOLOGIA, TENTATIVA DE SUICÍDIO E DESAFIOS PARA REDUÇÃO DAS INTOXICAÇÕES EXÓGENAS EM MOSSORÓ-RN
Maria Luíza de Oliveira Bezerra, Thallis Coelho da Silva Gramelich, Álvaro Marcos Pereira Lima
(2024)
Open Access
ABC Family Gene Polymorphisms and Cognitive Functions Interact to Influence Antidepressant Efficacy
Meijiang Jin, Lei Ji, Maojia Ran, et al.
Pharmacopsychiatry (2024) Vol. 58, Iss. 01, pp. 25-32
Closed Access
The place of selective serotonin reuptake inhibitors (SSRIs) in the treatment of depressive disorders in children and adolescents. Recommendations of the Main Board of the Polish Psychiatric Association. Part 2 – pharmacological properties and safety of use
Małgorzata Janas–Kozik, Agnieszka Słopień, Barbara Remberk, et al.
Psychiatria Polska (2023) Vol. 57, Iss. 5, pp. 917-940
Open Access
Page 1

Scroll to top